Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| VERTEX PHARMACEUTICALS INC / MAVRTX · Entity 2875 | VP & Controller | July 24, 2008 | July 25, 2008 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
VERTEX PHARMACEUTICALS INC / MA
Report date July 24, 2008 · Filed July 25, 2008
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $32.16 · Expires 2018-07-23 | Direct | 7,500 |
Reported balance
After 2008-07-24 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2008-07-24 · Grant · Acquired 7,500 · Balance 7,500 F1: Right to buy under 2006 Stock and Option Plan, vesting in 16 equal quarterly installments from 07/24/2008. |
Filing footnotes · ownership attribution and instrument terms
F1: Right to buy under 2006 Stock and Option Plan, vesting in 16 equal quarterly installments from 07/24/2008.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 13, 2007 Filed Aug 14, 2007 17:52 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 125 | $36.12 | $4,515.00 |
DisclosureSEC source: 0000875320-07-000089 · edgar.xml · nonDerivative · entry 2 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,564 F1 · kind: Transaction made pursuant to Ms. Messina-Power's company approved trading plan established under Rule 10b5-1. Read SEC document |
| August 13, 2007 Filed Aug 14, 2007 17:52 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionCommon Stock | 125 | $13.11 | $1,638.75 |
DisclosureSEC source: 0000875320-07-000089 · edgar.xml · nonDerivative · entry 1 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,689 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 06, 2007 Filed Aug 8, 2007 14:27 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionStock Option · Derivative | 125 | $0.00 Strike: $13.11 | $0.00 |
DisclosureSEC source: 0000875320-07-000088 · edgar.xml · derivative · entry 4 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,838 Underlying: Common Stock · 125 shares Expires 2009-12-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fully vested. Read SEC document |
| August 06, 2007 Filed Aug 8, 2007 14:27 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 125 | $34.68 | $4,335.00 |
DisclosureSEC source: 0000875320-07-000088 · edgar.xml · nonDerivative · entry 2 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,564 F1 · kind: Transaction made pursuant to Ms. Messina-Power's company approved trading plan established under Rule 10b5-1. Read SEC document |
| August 06, 2007 Filed Aug 8, 2007 14:27 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionCommon Stock | 125 | $13.11 | $1,638.75 |
DisclosureSEC source: 0000875320-07-000088 · edgar.xml · nonDerivative · entry 1 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,689 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 30, 2007 Filed Jul 31, 2007 15:53 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionStock Option · Derivative | 125 | $0.00 Strike: $13.11 | $0.00 |
DisclosureSEC source: 0000875320-07-000086 · edgar.xml · derivative · entry 4 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,963 Underlying: Common Stock · 125 shares Expires 2009-12-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fully vested. Read SEC document |
| July 30, 2007 Filed Jul 31, 2007 15:53 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 125 | $32.46 | $4,057.50 |
DisclosureSEC source: 0000875320-07-000086 · edgar.xml · nonDerivative · entry 2 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,564 F1 · kind: Transaction made pursuant to Ms. Messina-Power's company approved trading plan established under Rule 10b5-1. Read SEC document |
| July 30, 2007 Filed Jul 31, 2007 15:53 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionCommon Stock | 125 | $13.11 | $1,638.75 |
DisclosureSEC source: 0000875320-07-000086 · edgar.xml · nonDerivative · entry 1 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,689 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 25, 2007 Filed Jul 26, 2007 20:25 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionStock Option · Derivative | 128 | $0.00 Strike: $11.27 | $0.00 |
DisclosureSEC source: 0000875320-07-000085 · edgar.xml · derivative · entry 6 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 709 Underlying: Common Stock · 128 shares Expires 2014-10-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Right to buy under 1996 Stock and Option Plan, vesting quarterly over 4 years. Read SEC document |
| July 25, 2007 Filed Jul 26, 2007 20:25 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionStock Option · Derivative | 872 | $0.00 Strike: $13.11 | $0.00 |
DisclosureSEC source: 0000875320-07-000085 · edgar.xml · derivative · entry 5 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,088 Underlying: Common Stock · 872 shares Expires 2009-12-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fully vested. Read SEC document |
| July 25, 2007 Filed Jul 26, 2007 20:25 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 1,000 | $30.19 | $30,190.00 |
DisclosureSEC source: 0000875320-07-000085 · edgar.xml · nonDerivative · entry 3 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,564 F1 · kind: Transaction made pursuant to Ms. Messina-Power's company approved trading plan established under Rule 10b5-1. Read SEC document |
| July 25, 2007 Filed Jul 26, 2007 20:25 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionCommon Stock | 128 | $11.27 | $1,442.56 |
DisclosureSEC source: 0000875320-07-000085 · edgar.xml · nonDerivative · entry 2 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,564 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 25, 2007 Filed Jul 26, 2007 20:25 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionCommon Stock | 872 | $13.11 | $11,431.92 |
DisclosureSEC source: 0000875320-07-000085 · edgar.xml · nonDerivative · entry 1 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,436 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 12, 2007 Filed Jul 16, 2007 18:05 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | GrantStock Option · Derivative | 7,500 | $0.00 Strike: $28.84 | $0.00 |
DisclosureSEC source: 0000875320-07-000077 · edgar.xml · derivative · entry 1 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2017-07-11 F1 · derivative.exercise_date: Right to buy under 2006 Stock and Option Plan, vesting in 16 equal quarterly installments from 07/12/2007. Read SEC document |
| May 29, 2007 Filed May 30, 2007 16:35 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionStock Option · Derivative | 125 | $0.00 Strike: $11.27 | $0.00 |
DisclosureSEC source: 0000875320-07-000057 · edgar.xml · derivative · entry 4 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 837 Underlying: Common Stock · 125 shares Expires 2014-10-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Right to buy under 1996 Stock and Option Plan vesting in 16 equal quarterly installments from 10/7/2004. Read SEC document |
| May 29, 2007 Filed May 30, 2007 16:35 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 125 | $30.49 | $3,811.25 |
DisclosureSEC source: 0000875320-07-000057 · edgar.xml · nonDerivative · entry 2 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,564 F1 · kind: Transaction made pursuant to Ms. Messina-Power's company approved trading plan established under Rule 10b5-1. Read SEC document |
| May 29, 2007 Filed May 30, 2007 16:35 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionCommon Stock | 125 | $11.27 | $1,408.75 |
DisclosureSEC source: 0000875320-07-000057 · edgar.xml · nonDerivative · entry 1 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,689 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 21, 2007 Filed May 22, 2007 18:34 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionStock Option · Derivative | 125 | $0.00 Strike: $11.27 | $0.00 |
DisclosureSEC source: 0000875320-07-000055 · edgar.xml · derivative · entry 4 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 962 Underlying: Common Stock · 125 shares Expires 2014-10-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Right to buy under 1996 Stock and Option Plan vesting in 16 equal quarterly installments from 10/7/2004. Read SEC document |
| May 21, 2007 Filed May 22, 2007 18:34 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 125 | $31.56 | $3,945.00 |
DisclosureSEC source: 0000875320-07-000055 · edgar.xml · nonDerivative · entry 2 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,564 F1 · kind: Transaction made pursuant to Ms. Messina-Power's company approved trading plan established under Rule 10b5-1. Read SEC document |
| May 21, 2007 Filed May 22, 2007 18:34 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionCommon Stock | 125 | $11.27 | $1,408.75 |
DisclosureSEC source: 0000875320-07-000055 · edgar.xml · nonDerivative · entry 1 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,689 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 17, 2007 Filed May 21, 2007 19:24 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 220 | $31.95 | $7,029.00 |
DisclosureSEC source: 0000875320-07-000052 · edgar.xml · nonDerivative · entry 1 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,564 F1 · kind: Transaction made pursuant to Ms. Messina-Power's company approved trading plan established under rule 10b5-1. Read SEC document |
| May 14, 2007 Filed May 15, 2007 15:55 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionStock Option · Derivative | 125 | $0.00 Strike: $11.27 | $0.00 |
DisclosureSEC source: 0000875320-07-000049 · edgar.xml · derivative · entry 4 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,087 Underlying: Common Stock · 125 shares Expires 2014-10-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Right to buy under 1996 Stock and Option Plan vesting in 16 equal quarterly installments from 10/7/2004. Read SEC document |
| May 14, 2007 Filed May 15, 2007 15:55 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 125 | $30.05 | $3,756.25 |
DisclosureSEC source: 0000875320-07-000049 · edgar.xml · nonDerivative · entry 2 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,564 F1 · kind: Transaction made pursuant to Ms. Messina-Power's company approved trading plan established under Rule 10b5-1. Read SEC document |
| May 14, 2007 Filed May 15, 2007 15:55 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionCommon Stock | 125 | $11.27 | $1,408.75 |
DisclosureSEC source: 0000875320-07-000049 · edgar.xml · nonDerivative · entry 1 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,689 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 07, 2007 Filed May 9, 2007 15:36 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionStock Option · Derivative | 49 | $0.00 Strike: $11.27 | $0.00 |
DisclosureSEC source: 0000875320-07-000048 · edgar.xml · derivative · entry 6 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,212 Underlying: Common Stock · 49 shares Expires 2014-10-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Right to buy under 1996 Stock and Option Plan vesting in 16 equal quarterly installments from 10/7/2004. Read SEC document |
| May 07, 2007 Filed May 9, 2007 15:36 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 125 | $30.67 | $3,833.75 |
DisclosureSEC source: 0000875320-07-000048 · edgar.xml · nonDerivative · entry 3 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,564 F1 · kind: Transaction made pursuant to Ms. Messina-Power's company approved trading plan established under Rule 10b5-1. Read SEC document |
| May 07, 2007 Filed May 9, 2007 15:36 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionCommon Stock | 49 | $11.27 | $552.23 |
DisclosureSEC source: 0000875320-07-000048 · edgar.xml · nonDerivative · entry 2 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,689 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 07, 2007 Filed May 9, 2007 15:36 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionCommon Stock | 76 | $11.18 | $849.68 |
DisclosureSEC source: 0000875320-07-000048 · edgar.xml · nonDerivative · entry 1 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,640 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 30, 2007 Filed May 1, 2007 15:54 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionStock Option · Derivative | 125 | $0.00 Strike: $11.18 | $0.00 |
DisclosureSEC source: 0000875320-07-000040 · edgar.xml · derivative · entry 4 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76 Underlying: Common Stock · 125 shares Expires 2009-06-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fully vested. Read SEC document |
| April 30, 2007 Filed May 1, 2007 15:54 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 125 | $31.35 | $3,918.75 |
DisclosureSEC source: 0000875320-07-000040 · edgar.xml · nonDerivative · entry 2 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,564 F1 · kind: Transaction made pursuant to Ms. Messina-Power's company approved trading plan established under Rule 10b5-1. Read SEC document |
| April 30, 2007 Filed May 1, 2007 15:54 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionCommon Stock | 125 | $11.18 | $1,397.50 |
DisclosureSEC source: 0000875320-07-000040 · edgar.xml · nonDerivative · entry 1 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,689 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 30, 2007 Filed May 9, 2007 15:36 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionStock Option · Derivative | 76 | $0.00 Strike: $11.18 | $0.00 |
DisclosureSEC source: 0000875320-07-000048 · edgar.xml · derivative · entry 5 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 76 shares Expires 2009-06-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fully vested. Read SEC document |
| April 23, 2007 Filed Apr 24, 2007 16:32 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionStock Option · Derivative | 125 | $0.00 Strike: $11.18 | $0.00 |
DisclosureSEC source: 0000875320-07-000039 · edgar.xml · derivative · entry 4 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 201 Underlying: Common Stock · 125 shares Expires 2009-06-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fully vested. Read SEC document |
| April 23, 2007 Filed Apr 24, 2007 16:32 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 125 | $31.57 | $3,946.25 |
DisclosureSEC source: 0000875320-07-000039 · edgar.xml · nonDerivative · entry 2 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,564 F1 · kind: Transaction made pursuant to Ms. Messina-Power's company approved trading plan established under Rule 10b5-1. Read SEC document |
| April 23, 2007 Filed Apr 24, 2007 16:32 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionCommon Stock | 125 | $11.18 | $1,397.50 |
DisclosureSEC source: 0000875320-07-000039 · edgar.xml · nonDerivative · entry 1 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,689 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 17, 2007 Filed Apr 18, 2007 16:55 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionStock Option · Derivative | 125 | $0.00 Strike: $11.18 | $0.00 |
DisclosureSEC source: 0000875320-07-000038 · edgar.xml · derivative · entry 4 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 326 Underlying: Common Stock · 125 shares Expires 2009-06-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fully vested. Read SEC document |
| April 17, 2007 Filed Apr 18, 2007 16:55 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 125 | $30.00 | $3,750.00 |
DisclosureSEC source: 0000875320-07-000038 · edgar.xml · nonDerivative · entry 2 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,564 F1 · kind: Transaction made pursuant to Ms. Messina-Power's company approved trading plan established under Rule 10b5-1. Read SEC document |
| April 17, 2007 Filed Apr 18, 2007 16:55 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionCommon Stock | 125 | $11.18 | $1,397.50 |
DisclosureSEC source: 0000875320-07-000038 · edgar.xml · nonDerivative · entry 1 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,689 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 09, 2007 Filed Apr 10, 2007 18:09 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionStock Option · Derivative | 125 | $0.00 Strike: $11.18 | $0.00 |
DisclosureSEC source: 0000875320-07-000036 · edgar.xml · derivative · entry 4 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 451 Underlying: Common Stock · 125 shares Expires 2009-06-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fully vested. Read SEC document |
| April 09, 2007 Filed Apr 10, 2007 18:09 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 125 | $31.35 | $3,918.75 |
DisclosureSEC source: 0000875320-07-000036 · edgar.xml · nonDerivative · entry 2 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,564 F1 · kind: Transaction made pursuant to Ms. Messina-Power's company approved trading plan established under Rule 10b5-1. Read SEC document |
| April 09, 2007 Filed Apr 10, 2007 18:09 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionCommon Stock | 125 | $11.18 | $1,397.50 |
DisclosureSEC source: 0000875320-07-000036 · edgar.xml · nonDerivative · entry 1 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,689 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 04, 2007 Filed Apr 5, 2007 19:28 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionStock Option · Derivative | 125 | $0.00 Strike: $11.18 | $0.00 |
DisclosureSEC source: 0000875320-07-000035 · edgar.xml · derivative · entry 4 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 576 Underlying: Common Stock · 125 shares Expires 2009-06-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fully vested. Read SEC document |
| April 04, 2007 Filed Apr 5, 2007 19:28 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 125 | $30.00 | $3,750.00 |
DisclosureSEC source: 0000875320-07-000035 · edgar.xml · nonDerivative · entry 2 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,564 F1 · kind: Transaction made pursuant to Ms. Messina-Power's company approved trading plan established under Rule 10b5-1. Read SEC document |
| April 04, 2007 Filed Apr 5, 2007 19:28 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionCommon Stock | 125 | $11.18 | $1,397.50 |
DisclosureSEC source: 0000875320-07-000035 · edgar.xml · nonDerivative · entry 1 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,689 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 04, 2007 Filed Apr 8, 2008 20:03 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionStock Option · Derivative | 125 | $0.00 Strike: $13.11 | $0.00 |
DisclosureSEC source: 0000875320-08-000019 · edgar.xml · derivative · entry 4 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,963 Underlying: Common Stock · 125 shares Expires 2009-12-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Fully vested. Read SEC document |
| April 04, 2007 Filed Apr 8, 2008 20:03 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 125 | $30.00 | $3,750.00 |
DisclosureSEC source: 0000875320-08-000019 · edgar.xml · nonDerivative · entry 2 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,555 Read SEC document |
| April 04, 2007 Filed Apr 8, 2008 20:03 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionCommon Stock | 125 | $13.11 | $1,638.75 |
DisclosureSEC source: 0000875320-08-000019 · edgar.xml · nonDerivative · entry 1 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,680 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 02, 2007 Filed Apr 3, 2007 17:38 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 300 | $27.93 | $8,379.00 |
DisclosureSEC source: 0000875320-07-000033 · edgar.xml · nonDerivative · entry 1 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,864 F1 · kind: Transaction made pursuant to Ms. Messina-Power's company approved trading plan established under rule 10b5-1. Read SEC document |
| March 19, 2007 Filed Mar 20, 2007 16:39 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 23 | $27.39 | $629.97 |
DisclosureSEC source: 0000875320-07-000031 · edgar.xml · nonDerivative · entry 1 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,864 Read SEC document |
| March 12, 2007 Filed Mar 13, 2007 17:51 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionStock Option · Derivative | 125 | $0.00 Strike: $11.18 | $0.00 |
DisclosureSEC source: 0000875320-07-000030 · edgar.xml · derivative · entry 4 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 701 Underlying: Common Stock · 125 shares Expires 2009-06-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fully vested. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.